SCHEMBL874324

SCHEMBL874324

CNc1ccccc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.42
LMNA P02545 1/20 0.42
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
GAA P10253 1/20 0.41
ALDH1A1 P00352 3/20 0.40
HTT P42858 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
TRPV1 Q8NER1 2/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845350 0.91 MAPK1 (0.49) MAPK1LMNACYP2C9CYP2C19GAA
SCHEMBL10119639 0.88 MEN1 (0.46) MAPK1LMNACYP2C9CYP2C19GAA
SCHEMBL874056 0.88 TRPV1 (0.42) MAPK1CYP2C9CYP2C19ALDH1A1HTT
SCHEMBL874311 0.88 ALDH1A1 (0.47) LMNACYP2C9CYP2C19ALDH1A1HDAC3
SCHEMBL874313 0.87 MAPK1 (0.50) MAPK1LMNACYP2C9CYP2C19GAA
SCHEMBL10119551 0.86 DHODH (0.40) CYP2C9CYP2C19GAAALDH1A1TRPV1
SCHEMBL10119315 0.86 MAPT (0.40) MAPK1CYP2C9CYP2C19ALDH1A1HTT
SCHEMBL10119344 0.86 CYP2C9 (0.39) MAPK1CYP2C9CYP2C19ALDH1A1HTT
SCHEMBL872532 0.86 TRPV1 (0.44) MAPK1CYP2C9CYP2C19ALDH1A1HTT
SCHEMBL10119502 0.86 CYP2C9 (0.39) MAPK1CYP2C9CYP2C19ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed